Donald W. Landry is the Interim Chair of Medicine and Director of the Division of Experimental Therapeutics. He is the leading proponent of an alternative method for the production of human embryonic stem cells that relies on harvesting live, normal cells from embryos that by objective, peer reviewed criteria, have died of natural causes. By conducting natural history studies on human embryos engendered for the purpose of reproduction, he is precisely defining death in embryos based on arrested growth. Several groups worldwide have confirmed his hypothesis. Cells harvested from dead embryos would be covered under the established ethics undergirding essential organ donation from deceased donors.
Landry DW, Zucker HA, Sauer MV, Reznik M, Wiebe L. Hypocellularity and absence of compaction as criteria for embryonic death. Regen Med. 2006 May;1(3):367-71.
Landry DW, Zucker HA. Embryonic death and the creation of human embryonic stem cells. J Clin Invest. 2004 Nov;114(9):1184-6. Review.